When Security Monitoring Is a Side Job, Biotech Pays a Price
Biotech Security Breaks Down When Monitoring Becomes Someone’s Side Job The false belief is that a biotech company can delay 24/7 security operations until it reaches enterprise scale. That sounds financially responsible. It is often operationally reckless. The issue is not whether a biotech firm under $100M can afford a massive internal SOC. Most cannot, […]